Report Overview: The Global Epigenetics Market achieved a valuation of $1.9 Billion in 2022 and is anticipated to exceed $4.41 Billion by 2030, reflecting a compounded annual growth rate (CAGR) of 12.8% during the forecast period from 2024 to 2032. Key Market Players: Illumina (US), Thermo Fisher Scientific (US), Merck Millipore (US), Abcam (UK), Active Motif (US), Bio-Rad...